PHATHOM PHARMACEUTICALS, INC. (PHAT) Operating cash flow 2018–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$166.8MFY2025 · since FY2018: -$1.0M → -$166.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$166.8M | +37.5% |
| FY2024 | -$266.8M | -93.9% |
| FY2023 | -$137.6M | +6.1% |
| FY2022 | -$146.5M | +1.3% |
| FY2021 | -$148.5M | -113.0% |
| FY2020 | -$69.7M | -90.9% |
| FY2019 | -$36.5M | -3468.9% |
| FY2018 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net incomePHAT Net marginPHAT Gross profitPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →